The U.S. Chemical Safety Board (CSB) will convene a public meeting on October 21, 2015, starting at 1 p.m. EDT in Washington, DC at the Palomar Hotel, 2121 P St, NW, in the Phillips Ballroom.
The meeting is free and open to the public. This meeting will be webcast for those who cannot attend in person. Please visit https://bluejeans.com/353779816/ at the time of the meeting to watch the live webcast.
The Board will discuss the final report and recommendations from the Caribbean Petroleum incident. The Board may then vote on the Caribbean Petroleum report. For more information on the CSB's investigation into the accident at Caribbean Petroleum, please visit our investigation page.
The Board will also discuss the status of several current CSB investigations, including ExxonMobil Torrance, West Fertilizer, Freedom Industries, DuPont LaPorte, Macondo, and Williams Olefins. And the Board will discuss the agency action plan for FY 15 in addition to the newly confirmed Chairperson’s overview of her first 60 days.
An opportunity for public comment will be provided. The time provided for public statements will depend upon the number of people who wish to speak. Speakers should assume that their presentations will be limited to three minutes or less, but commenters may submit written statements for the record. Those unable to attend the meeting in person, may submit public comments via email to [email protected].
The CSB is an independent federal agency charged with investigating accidents and hazards that result, or may result, in the catastrophic release of extremely hazardous substances. The agency’s Board Members are appointed by the President and confirmed by the Senate. CSB investigations look into all aspects of chemical accidents and hazards, including physical causes such as equipment failure as well as inadequacies in regulations, industry standards, and safety management systems.
For further Information please see the Federal Register Notice or contact Shauna Lawhorne, Public Affairs Specialist, [email protected] or (202) 384-2839.